Replimune (REPL) Enterprise Value (2018 - 2026)

Replimune has reported Enterprise Value for 9 years, with the latest figure at -$268.9 million in Q1 2026.

• Quarterly Enterprise Value rose 44.42% year-over-year to -$268.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$268.9 million (up 44.42% YoY) and the FY2026 annual result came in at -$268.9 million, up 44.42% from the prior year.
• Enterprise Value was little changed at -$268.9 million in Q1 2026 per REPL's latest filing, from -$269.1 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$268.9 million in Q1 2026 and troughed at -$616.4 million in Q4 2022.
• A 5-year average of -$437.7 million and a median of -$432.1 million in 2024 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value sank 59.92% in 2023, then surged 49.84% in 2025.
• Over 5 years, Enterprise Value stood at -$616.4 million in 2022, then increased by 24.34% to -$466.4 million in 2023, then decreased by 15.05% to -$536.5 million in 2024, then soared by 49.84% to -$269.1 million in 2025, then increased by 0.09% to -$268.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$268.9 million, -$269.1 million, and -$323.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.